Alliance Pharma plc (APH) Hits New 52-Week High at $60.00
Alliance Pharma plc (LON:APH)’s share price hit a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 60 ($0.80) and last traded at GBX 58.75 ($0.78), with a volume of 764,413 shares traded. The stock had previously closed at GBX 59 ($0.78).
A number of brokerages recently issued reports on APH. N+1 Singer restated a “not rated” rating on shares of Alliance Pharma plc in a research note on Wednesday, September 13th. Numis Securities Ltd restated a “buy” rating and issued a GBX 60 ($0.80) target price on shares of Alliance Pharma plc in a research note on Wednesday, September 13th. FinnCap restated a “buy” rating and issued a GBX 58 ($0.77) target price on shares of Alliance Pharma plc in a research note on Thursday, September 14th. Finally, Investec began coverage on Alliance Pharma plc in a research note on Wednesday, September 13th. They issued a “buy” rating and a GBX 59 ($0.78) target price for the company.
The stock’s market capitalization is GBX 279.90 million. The stock has a 50-day moving average price of GBX 54.25 and a 200 day moving average price of GBX 51.84.
The firm also recently announced a dividend, which will be paid on Thursday, January 11th. Stockholders of record on Thursday, December 21st will be issued a GBX 0.44 ($0.01) dividend. The ex-dividend date of this dividend is Thursday, December 21st. This represents a dividend yield of 0.84%.
TRADEMARK VIOLATION NOTICE: “Alliance Pharma plc (APH) Hits New 52-Week High at $60.00” was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://www.watchlistnews.com/alliance-pharma-plc-aph-hits-new-52-week-high-at-60-00/1637692.html.
Alliance Pharma plc Company Profile
Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international.
Receive News & Ratings for Alliance Pharma plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma plc and related companies with Analyst Ratings Network's FREE daily email newsletter.